Morgan Stanley Capital Partners (MSCP) has closed North Haven Capital Partners VIII at $3.2bn, marking a 60% increase over its predecessor and underscoring strong investor demand for the firm’s U.S. middle-market strategy.

The fund, which was significantly oversubscribed and closed in under 12 months, exceeded its $2.5bn target and hit its $3bn hard cap. Including additional capital from Morgan Stanley’s strategic accounts, total commitments reached $3.2bn.

Fund VIII drew commitments from a global mix of institutional LPs, family offices, and Morgan Stanley Wealth Management clients across North and South America, Europe, and Asia.

MSCP will maintain its longstanding strategy of control investments in founder-led and entrepreneur-driven businesses across business, consumer, healthcare, and industrial services. The firm will continue to apply its proprietary value creation playbook, focused on operational improvement, market expansion, and organic growth acceleration.

“We are excited to have capital to invest in a changing landscape, where valuations may prove more favourable than in past years,” said Aaron Sack, Head of MSCP. “We believe the U.S. middle market remains a dynamic engine of growth.”

Approximately 17% of Fund VIII has already been deployed into three platform investments: American Restoration, FoodScience, and Thermogenics. Each reflects MSCP’s sector-focused, operationally engaged approach to value creation.

David N. Miller, Global Head of Private Credit and Equity, added: “This fundraise underscores investor confidence in MSCP’s model – leveraging the scale of Morgan Stanley with the operational expertise of its in-house team.”

If you think we missed any important news, please do not hesitate to contact us at news@pe-insights.com.

Can`t stop reading? Read more.